The CAP-IASLC-AMP molecular testing guideline for the selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors Meeting Abstract
| Authors: | Ladanyi, M.; Cagle, P. T.; Beasley, M. B.; Chitale, D.; Dacic, S.; Giaccone, G.; Jenkins, R. B.; Kwiatkowski, D. J.; Saldivar, J. S.; Squire, J.; Thunnissen, E.; Lindeman, N. I. |
| Abstract Title: | The CAP-IASLC-AMP molecular testing guideline for the selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419600502 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.11085 |
| Notes: | Meeting Abstract: 11085 -- Source: Wos |
